Scholars Central

Conference abstractPublished 11 Jul 2016

GLP-1 receptor agonist exacerbates mucus hyper secretory phenotype in βENaC-transgenic mouse with obstructive lung diseases

Authors: Hirofumi Nohara, Tsuyoshi Shuto, Ryunosuke Nakashima, Shunsuke Kamei, Haruka Fujikawa, Kasumi Maruta, Mary Ann Suico, Hirofumi Kai

Kumamoto University, Japan

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic obstructive pulmonary disease (COPD) is mainly characterized by airway mucus obstruction, chronic infl ammation and emphysema. Identifi cation of novel factors that control the COPD pulmonary phenotypes is an important issue for better treatment of COPD patients. Glucagon like peptide-1 (GLP-1) is a gastrointestinal hormone and because of its pancreatic supporting function, GLP-1 receptor agonist is clinically used as a drug for the treatment of type-2 diabetes. Interestingly, GLP-1 receptor is highly expressed in lung tissue compared with other tissues. But little is known about the physiological and pathophysiological roles of GLP-1 in lung. Here, we showed that intratracheal treatment of airway specifi c Ã?²ENaC (epithelial Na+ channel Ã?² subunit)- transgenic mice, a murine model of COPD that basically exhibits airway mucus obstruction with GLP-1 receptor agonist Exendin-4 (10 pmol/day, 2 weeks) signifi cantly up regulates mucin gene expression in lung tissue. Moreover, Exendin-4 signifi cantly increased the alveolar mean linear intercept (MLI), a measure of emphysema in Ã?²ENaC-Tg mice. Notably, GLP-1 receptor agonist (Exendin-4 and Liraglutide) treatment (0.1 nM, 6-12 hours) also enhanced mucin expression in Ã?²/Ã?³ENaC-over expressing 16HBE14o-cells and the eff ect was possibly induced by p38 MAP kinase pathway. Despite observations of Exendin-4-dependent mucin up regulation in WT mice and parental 16HBE14o cells, exacerbation of pulmonary phenotypes was not observed in these conditions. Together, our studies demonstrate that pulmonary GLP-1 signal exacerbates the phenotypes of Ã?²ENaC-Tg mice at least partly viap38MAPKdependent mucin induction and our data may caution against the clinical use of inhaled GLP-1 receptor agonist in COPD patients with type-2 diabetes.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Pulmonary & Respiratory Medicine.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPulmonary & Respiratory Medicine
  • SubjectPulmonology & Respiratory
  • BylineArticles whose byline prints “Hirofumi Nohara”
  • BylineArticles whose byline prints “Tsuyoshi Shuto”
  • BylineArticles whose byline prints “Ryunosuke Nakashima”
  • BylineArticles whose byline prints “Shunsuke Kamei”
  • BylineArticles whose byline prints “Haruka Fujikawa”
  • BylineArticles whose byline prints “Kasumi Maruta”
  • BylineArticles whose byline prints “Mary Ann Suico”
  • BylineArticles whose byline prints “Hirofumi Kai”